There are currently 15 clinical trials in Quincy, Massachusetts looking for participants to engage in research studies. Trials are conducted at various facilities, including Beacon Clinical Research, LLC, Dana Farber Community Cancer Care-Quincy and Commonwealth Hematology-Oncology P. C. - Quincy. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Recruiting
To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome
Gender:
All
Ages:
14 years and above
Trial Updated:
04/11/2024
Locations: Site #5, Quincy, Massachusetts
Conditions: Netherton Syndrome
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
Recruiting
The investigators propose to test the use of pramipexole in patients being treated for Opioid Use Disorder to test its ability to reduce symptoms of both Restless Legs Syndrome and protracted opioid withdrawal and thereby promote initiation, engagement, and retention in treatment.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
03/11/2024
Locations: Gavin Foundation Clinical Stabilization Services, Quincy, Massachusetts
Conditions: Sleep Disorder, Restless Legs Syndrome, Opioid-use Disorder, Opioid Withdrawal
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
Recruiting
Multicenter, randomized, double-blind, placebo-controlled, parallel arm clinical study designed to evaluate the efficacy and safety of eblasakimab in participants with moderate-to-severe atopic dermatitis (AD) previously treated with dupilumab.The study consists of a 16-week treatment period and an 8-week follow-up period up to Week 24. Eligible participants will be randomized into one of the 2 treatment arms.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/17/2024
Locations: ASLAN Investigative Site, Quincy, Massachusetts
Conditions: Atopic Dermatitis